Medtronic, Mazor Robotics close $40 million round

Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in…

Cambridge Medical Robotics unveils first look at Versius ‘bot

Cambridge Medical Robotics released the first photos today of its surgical robot, Versius, designed to make minimal access surgery more widely available and easier to perform. “We’ve designed Versius with surgeons in mind. By equipping them with a remarkable tool, fit for their demanding job, we can change the way surgery is delivered,” CEO Martin…

Titan Medical CEO wants to up the game in robotic surgery: Here’s how

Titan Medical – the young, upstart Canadian robotic surgery company – is making a comeback this year. Just today, the company announced the completion of initial formative human factors studies for its Sport single port robotic surgical system. The Sport system boasts the ability for a variety of surgical instruments on snake-like arms to be deployed

Robotic surgery is taking off: Here’s what you need to know

[<a href=”//storify.com/MedTechDaily/getting-started” target=”_blank”>View the story “Robotic surgery: Here’s everything you need to know” on Storify</a>] [Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

How Cambridge Medical Robotics wants to transform robotic surgery

The field of surgical robotics is rapidly changing. (Check out our ongoing surgical robotics series). Major players in the field include Cambridge Medical Robotics (CMR), a U.K.-based OEM working on a portable surgical robot called the Versius. CMR recently completed Series A financing, and CEO Martin Frost believes the technology will transform the existing market. Frost answered some

Why our grandkids will laugh at today’s surgical robots

For the last 10 years, if anyone mentioned robotic surgery or surgical robots, 95% of the time they meant the da Vinci robot from Intuitive Surgical. “That product has been so dominantly successful that almost everybody who talks about it is talking with that as their reference point,” said Roger Smith, chief technology officer for

Intuitive Surgical expects slowdown in da Vinci sales growth

Intuitive Surgical beat Wall Street expectations with its fourth quarter results, but company officials expect a slowdown in sales growth this year for da Vinci surgical robots. Intuitive Surgical earned $204 million, or $5.13 per share, off $386 million in sales during the three months ended Dec. 31, 2016, the company reported Tuesday evening. The fourth